GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy. To start a conversation on this topic...
Did you recently receive a diagnosis of non small cell lung cancer? GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lung cancer experts listed below. David R. Gandara, MD Melissa L. Johnson, MD Suresh S. Ramalingam, MD Heather Wakelee, MD H. Jack West, MD
Genetic Testing - Navigating the Insurance Process The oncology field is constantly innovating and changing, and in response so are testing methods to determine the location of the cancer, monitor progression, and metastases, and most recently to determine the most effective treatment option. Typically, when monitoring your cancer or determining progression your oncologist may order either a tissue biopsy or a liquid biopsy. A standard tissue biopsy is when the specimen is taken directly from...
As the payer landscape continuously changes so do many insurance companies and their cancer medication requirements. One important class of drugs that is facing constant change and is given with many traditional cancer treatments are granulocyte colony stimulating factors ( G-CSF). G-CSFs stimulate the bone marrow to produce white blood cells; which reduces the risk of infection and speeds up the recovery from neutropenia after intensive chemotherapy regimens. Neutropenia is a condition where...
With the insurance payer landscape changing every day, one important demographic facing the backlash of these changes are cancer patients. Cancer research has resulted in expanding treatment options and rapid approval of many high-cost cancer drugs. However, insurance companies have struggled to update their medical policies and keep up in their provision of adequate coverage and access to care. One particular drug class that has received a lot of recent attention is immunotherapy. Immunotherapy...
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in Targeted Therapies for Lung Cancer Have a chance to talk with the doctors about the newest information in targeted therapies. Some potential topics our faculty will be discussing include: NGS: Current Status, Barriers and Emerging Targets Liquid Biopsies as a New Option: How Does it Fit In? What is the Role for Rebiopsy Today? Presentations by Lung...